Pricing Log in Create free account

Biomea Fusion, Inc. (BMEA) vs Serina Therapeutics, Inc. (SER)

Biomea Fusion, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Biomea Fusion, Inc. and Serina Therapeutics, Inc. are of similar size ($42.6M and $41.9M). Across the 10 metrics below, Biomea Fusion, Inc. leads on 5 and Serina Therapeutics, Inc. on 5.

Valuation

Metric BMEA SER Biotechnology median
P/E n/m n/m 10.60
P/S n/m 126.73 9.40
P/B 3.34 1.22 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 32.54 9.02
Earnings yield (88.54%) (135.00%) (32.88%)
Free cash flow yield (115.76%) (92.42%) (23.13%)

Profitability

Metric BMEA SER Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (164.14%) (306.22%) (51.96%)
Return on assets (59.14%) (136.00%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BMEA SER Biotechnology median
Revenue growth (TTM) — (94.21%) 6.76%
EPS growth (last fiscal year) 69.19% (26.49%) 29.88%
Revenue growth, 5-year CAGR — (18.48%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BMEA SER Biotechnology median
Debt to equity 0.00 0.16 0.00
Current ratio 3.48 6.65 4.97
Net debt to EBITDA 0.68 0.00 1.01

Dividend

Metric BMEA SER Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BMEA SER Biotechnology median
Market cap 42.57m 41.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack